Award
National Institute of Allergy and Infectious Diseases 5R01AI173780-04
Harnessing activated CD4 T cells to define new mechanisms of protection in tuberculosis
Recipient
National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH
Award Amount
$590,248.00
Ceiling
$590,248.00
Awarded
June 10, 2026
Identifier
5R01AI173780-04
NIH awarded a project to study immunotherapy for tuberculosis by targeting activated CD4 T cells using advanced RNA sequencing techniques to develop new treatments.
Description
This is a NIH-funded project focused on immunotherapy for tuberculosis, specifically targeting activated CD4 T cells and OX40 agonist treatment. The project involves advanced single-cell RNA sequencing and TCR profiling to understand immune mechanisms and develop new therapeutic strategies.